Apocynin exhibits an ameliorative effect on endothelial dysfunction/ atherosclerosis-related factors in high-fat diet-induced obesity in rats

Abstract

Objective: The aim of this study was to reveal the effect of apocynin (APO) on the factors involved in obesity-related endothelial dysfunction (ED) and atherosclerosis (AS). Materials and Methods: Male Wistar albino rats were divided into control (CNT), high-fat diet (HFD) and HFD+APO groups. HFD and HFD+APO groups were fed HFD for sixteen weeks. APO (25 mg/kg) was administered to the HFD+APO group for the last four weeks. The effects of APO on: AS-related metabolic parameters (triglyceride, total cholesterol, high-density lipoprotein-cholesterol, insulin and leptin), oxidative stress (OS), [ malondialdehyde, glutathione, nicotinamide adenine dinucleotide phosphate (NADPH)- oxidase-2, oxidised-low-density lipoprotein (ox-LDL) and 8-hydroxy-2-deoxyguanosine], low-density lipoprotein and ox-LDL uptake potential (activin receptor-like kinase-1 and lectin-like oxidized low-density lipoprotein receptor-1, respectively), tissue inflammation (myeloperoxidase, monocyte-chemoattractant-protein-1, tumor necrosis factor-alpha), ED (endothelial-nitric oxide synthase, inducible-nitric oxide synthase, nitric oxide), programmed cell death (terminal deoxynucleotidyl-transferase-dUTP-nick-end labeling, cleaved-poly-ADP-ribose-polymerase, gasdermin-D N-terminal fragment, caspase-1), smooth muscle cell transformation (alpha-smooth muscle actin), histology and ultrastructure of thoracic aorta were evaluated. Results: In obesity, APO had an ameliorative effect on metabolic parameters, OS, inflammation, ED, programmed cell death and ox- LDL uptake potential, but not on foam cell formation and LDL uptake potential. Conclusion: Apocynin may improve ED and AS in obesity by suppressing OS-linked factors involved in the early stage of AS.

Keywords

• Apocynin
• Atherosclerosis
• Endothelial dysfunction
• Oxidative stress
• Obesity
• High-fat diet

References

1. Pastore I, Bolla AM, Montefusco L, et al. The Impact of Diabetes Mellitus on Cardiovascular Risk Onset in Children and Adolescents. Int J Mol Sci 2020; 21:4928-45. doi: 10.3390/ ijms21144928.
2. Kinoshita H, Matsumura T, Ishii N, et al. Apocynin suppresses the progression of atherosclerosis in apoE-deficient mice by inactivation of macrophages. Biochem Biophys Res Commun. 2013; 431:124-30. doi: 10.1016/j.bbrc.2013.01.014.
3. Du J, Fan LM, Mai A, Li JM. Crucial roles of Nox2-derived oxidative stress in deteriorating the function of insulin receptors and endothelium in dietary obesity of middleaged mice. Br J Pharmacol 2013; 170:1064-77. doi: 10.1111/ bph.12336.
4. Gamez-Mendez AM, Vargas-Robles H, Ríos A, Escalante B. Oxidative Stress-Dependent Coronary Endothelial Dysfunction in Obese Mice. PLoS One 2015;10m: e0138609. doi: 10.1371/journal.pone.0138609.
5. Incalza MA, D’Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol 2018; 100:1-19. doi: 10.1016/j.vph.2017.05.005.
6. Lozano I, Van der Werf R, Bietiger W, et al. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab (Lond) 2016; 13:15-28. doi: 10.1186/s12986.016.0074-1.
7. Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative Stress in Atherosclerosis. Curr Atheroscler Rep 2017;19: 42- 53. doi: 10.1007/s11883.017.0678-6.
8. Yang S, Liu L, Meng L, Hu X. Capsaicin is beneficial to hyperlipidemia, oxidative stress, endothelial dysfunction, and atherosclerosis in Guinea pigs fed on a high-fat diet. Chem Biol Interact 2019; 297:1-7. doi: 10.1016/j.cbi.2018.10.006.

9. Hartley A, Haskard D, Khamis R. Oxidized LDL and antioxidized LDL antibodies in atherosclerosis – Novel insights and future directions in diagnosis and therapy. Trends Cardiovasc Med 2019;29: 22-26. doi: 10.1016/j.tcm.2018.05.010.
10. Tao B, Kraehling JR, Ghaffari S, et al. BMP-9 and LDL crosstalk regulates ALK-1 endocytosis and LDL transcytosis in endothelial cells. J Biol Chem 2020; 295:18179-18188. doi: 10.1074/jbc.RA120.015680.
11. Lund AK, Lucero J, Harman M, et al. The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions. Am J Respir Crit Care Med 2011; 184:82- 91. doi: 10.1164/rccm.201.012.1967OC.
12. Mehta JL, Sanada N, Hu CP, et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res. 2007; 100:1634-42. doi: 10.1161/ CIRCRESAHA.107.149724.
13. Savla SR, Laddha AP, Kulkarni YA. Pharmacology of apocynin: a natural acetophenone. Drug Metab Rev 2021; 53:542-562. doi: 10.1080/03602.532.2021.1895203.
14. Perassa LA, Graton ME, Potje SR, et al. Apocynin reduces blood pressure and restores the proper function of vascular endothelium in SHR. Vascul Pharmacol 2016; 87:38-48. doi: 10.1016/j.vph.2016.06.005.
15. Olukman M, Orhan CE, Celenk FG, Ulker S. Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions. J Diabetes Complications 2010; 24:415- 23. doi: 10.1016/j.jdiacomp.2010.02.001.
16. Köroğlu KM, Çevik Ö, Şener G, Ercan F. Apocynin alleviates cisplatin-induced testicular cytotoxicity by regulating oxidative stress and apoptosis in rats. Andrologia 2019;51: e13227. doi: 10.1111/and.13227.
17. Castro MM, Rizzi E, Rodrigues GJ, et al. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. Free Radic Biol Med 2009; 46:1298-307. doi: 10.1016/j.freeradbiomed.2009.02.011.
18. Fan R, Shan X, Qian H, et al. Protective effect of apocynin in an established alcoholic steatohepatitis rat model. Immunopharmacol Immunotoxicol 2012; 34:633-8. doi: 10.3109/08923.973.2011.648266.
19. Wu M, Xing Q, Duan H, Qin G, Sang N. Suppression of NADPH oxidase 4 inhibits PM2.5-induced cardiac fibrosis through ROS-P38 MAPK pathway. Sci Total Environ 2022; 837:155558. doi: 10.1016/j.scitotenv.2022.155558.
20. Zhang R, Ran HH, Ma J, Bai YG, Lin LJ. NAD(P)H oxidase inhibiting with apocynin improved vascular reactivity in tailsuspended hindlimb unweighting rat. J Physiol Biochem. 2012; 68:99-105. doi: 10.1007/s13105.011.0123-1.
21. Cheng X, Zheng X, Song Y, et al. Apocynin attenuates renal fibrosis via inhibition of NOXs-ROS-ERK-myofibroblast accumulation in UUO rats. Free Radic Res 2016; 50:840-52. doi: 10.1080/10715.762.2016.1181757.
22. Kinkade K, Streeter J, Miller FJ. Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. Int J Mol Sci 2013; 14:17017-28. doi: 10.3390/ijms140817017.
23. Affane F, Louala S, El Imane Harrat N, et al. Hypolipidemic, antioxidant and antiatherogenic property of sardine byproducts proteins in high-fat diet induced obese rats. Life Sci 2018; 199:16-22. doi: 10.1016/j.lfs.2018.03.001.
24. Kuru Yaşar R, Kuru D, Şen A, Şener G, Ercan F, Yarat A. Effects of Myrtus communis L. Extract and Apocynin on Lens Oxidative Damage and Boron Levels in Rats with a High Fat- Diet. Turk J Ophthalmol 2021;51(6):344-350. doi: 10.4274/tjo. galenos.2021.27981.
25. Love KM, Liu Z. DPP4 Activity, Hyperinsulinemia, and Atherosclerosis. J Clin Endocrinol Metab 2021; 106:1553- 1565. doi: 10.1210/clinem/dgab078.
26. Meng R, Zhu DL, Bi Y, Yang DH, Wang YP. Anti-oxidative effect of apocynin on insulin resistance in high-fat diet mice. Ann Clin Lab Sci 2011; 41:236-43.
27. Yan M, Mehta JL, Hu C. LOX-1 and obesity. Cardiovasc Drugs Ther 2011; 25:469-76. doi: 10.1007/s10557.011.6335-3.
28. Chung APYS, Gurtu S, Chakravarthi S, Moorthy M, Palanisamy UD. Geraniin Protects High-Fat Diet-Induced Oxidative Stress in Sprague Dawley Rats. Front Nutr 2018; 5:17. doi: 10.3389/fnut.2018.00017.
29. Costa CA, Amaral TA, Carvalho LC, et al. Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension. Am J Hypertens 2009; 22:1242-9. doi: 10.1038/ajh.2009.186.
30. Qin F, Simeone M, Patel R. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction. Free Radic Biol Med 2007; 43:271-81. doi: 10.1016/j.freeradbiomed.2007.04.021.
31. Moe KT, Aulia S, Jiang F, et al. Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells. J Cell Mol Med 2006;10:231-9. doi: 10.1111/ j.1582-4934.2006.tb00304.x.
32. Zhang H, Cui J, Zhang C. Emerging role of adipokines as mediators in atherosclerosis. World J Cardiol 2010; 2:370-6. doi: 10.4330/wjc.v2.i11.370.
33. Meng R, Zhu DL, Bi Y, Yang DH, Wang YP. Apocynin improves insulin resistance through suppressing inflammation in high-fat diet-induced obese mice. Mediators Inflamm 2010; 2010:858735. doi: 10.1155/2010/858735.
34. Münzel T, Camici GG, Maack C, Bonetti NR, Fuster V, Kovacic JC. Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series. J Am Coll Cardiol 2017;70:212-229. doi: 10.1016/j.jacc.2017.05.035.
35. Li H, Horke S, Förstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis 2014;237:208-19. doi: 10.1016/j.atherosclerosis.2014.09.001.
36. Chung JH, Moon J, Lee YS, Chung HK, Lee SM, Shin MJ. Arginase inhibition restores endothelial function in dietinduced obesity. Biochem Biophys Res Commun 2014 ;451:179-83. doi: 10.1016/j.bbrc.2014.07.083.
37. La Favor JD, Dubis GS, Yan H, White JD, Nelson MA, Anderson EJ, Hickner RC. Microvascular Endothelial Dysfunction in Sedentary, Obese Humans Is Mediated by NADPH Oxidase: Influence of Exercise Training. Arterioscler Thromb Vasc Biol 2016; 36:2412-2420. doi: 10.1161/ATVBAHA.116.308339.
38. Jang E, Robert J, Rohrer L, von Eckardstein A, Lee WL. Transendothelial transport of lipoproteins. Atherosclerosis 2020; 315:111-125. doi: 10.1016/j.atherosclerosis.2020.09.020.
39. Chang WC, Yu YM, Hsu YM, Wu CH, Yin PL, Chiang SY, Hung JS. Inhibitory effect of Magnolia officinalis and lovastatin on aortic oxidative stress and apoptosis in hyperlipidemic rabbits. J Cardiovasc Pharmacol 2006; 47:463-8. doi: 10.1097/01. fjc.000.021.1708.03111.6e.
40. Kattoor AJ, Goel A, Mehta JL. LOX-1: Regulation, Signaling and Its Role in Atherosclerosis. Antioxidants (Basel) 2019; 8:218-33. doi: 10.3390/antiox8070218.
41. Rathouska J, Vecerova L, Strasky Z, et al. Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis. Pharmacol Res 2011; 64:53-9. doi: 10.1016/j.phrs.2011.03.008.
42. Chellan B, Sutton NR, Hofmann Bowman MA. S100/ RAGE-Mediated Inflammation and Modified Cholesterol Lipoproteins as Mediators of Osteoblastic Differentiation of Vascular Smooth Muscle Cells. Front Cardiovasc Med 2018; 5:163. doi: 10.3389/fcvm.2018.00163.
43. Chaabane C, Coen M, Bochaton-Piallat ML. Smooth muscle cell phenotypic switch: implications for foam cell formation. Curr Opin Lipidol 2014; 25:374-9. doi: 10.1097/ MOL.000.000.0000000113.
44. Li M, Wang ZW, Fang LJ, Cheng SQ, Wang X, Liu NF. Programmed cell death in atherosclerosis and vascular calcification. Cell Death Dis 2022; 13:467. doi: 10.1038/ s41419.022.04923-5.
45. Shan R, Liu N, Yan Y, Liu B. Apoptosis, autophagy and atherosclerosis: Relationships and the role of Hsp27. Pharmacol Res 2021;166:105169. doi: 10.1016/j.phrs.2020.105169.
46. Xu YJ, Zheng L, Hu YW, Wang Q. Pyroptosis and its relationship to atherosclerosis. Clin Chim Acta 2018;476:28- 37. doi: 10.1016/j.cca.2017.11.005.
47. Liu Z, Yao X, Jiang W, et al. Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-κB signaling pathway and pyroptosis after secondary spinal cord injury. J Neuroinflammation 2020; 17:90. doi: 10.1186/s12974.020.01751-2.
48. Hersek İ, Köroğlu MK, Coskunlu B, Ertaş B, Şener G, Ercan F. Apocynin ameliorates testicular toxicity in high-fat diet-fed rats by regulating oxidative stress, Clin Exp Health Sci 2023, 13: 75-83. doi:10.33808/clinexphealthsci.1035133
49. Zhaolin Z, Guohua L, Shiyuan W, Zuo W. Role of pyroptosis in cardiovascular disease. Cell Prolif 2019;52:e12563. doi: 10.1111/cpr.12563.
50. Di Pietro N, Formoso G, Pandolfi A. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vascul Pharmacol 2016;84:1-7. doi: 10.1016/j. vph.2016.05.013.